Kyoto, Japan
Kyoto, Japan

Kyoto University , or Kyodai is a national university located in Kyoto, Japan. It is the second oldest Japanese university, one of the highest ranked universities in Asia and one of Japan's National Seven Universities. One of Asia’s leading research-oriented institutions, Kyoto University is famed for producing world-class researchers, including ten Nobel Prize laureates, two Fields medalists and one Gauss Prize. Wikipedia.


Time filter

Source Type

Patent
Japan Tobacco Inc. and Kyoto University | Date: 2016-03-16

[PROBLEM] The problem to be solved by the invention is to provide a novel pharmaceutical use of a JAK inhibitor. [SOLUTION MEANS] A therapeutic or preventive agent for a skin disease selected from the group consisting of senile xerosis, asteatosis, eczema and contact dermatitis, containing a JAK inhibitor as an active ingredient. [EFFECT] The followings are found: a JAK inhibitor increases the expression amounts of filaggrin, loricrin, involucrin and -defensin 3 as skin barrier function-related proteins; a JAK inhibitor significantly increases NMF production in a Tape Stripping-treated mouse; and a JAK inhibitor significantly accelerates a reduction in TEWL in a dry skin mouse model, namely improves the skin barrier function. The JAK inhibitor can be used as an active ingredient of a therapeutic or preventive agent for skin diseases such as senile xerosis, asteatosis, eczema, contact dermatitis, ichthyosis vulgaris, Netherton syndrome, type B peeling skin syndrome, etc.


Patent
Kyoto University | Date: 2016-08-24

A translational control method using an RNA-protein interaction motif is provided. The method comprises a step of introducing an mRNA having: a 5UTR regulation structure comprising: (1) a cap structure at the 5 terminus, (2) a spacer positioned on the 3 side of the cap structure, and (3) one or more RNA motifs positioned on the 3 side of the spacer, which comprises an RNA-protein interaction motif-derived nucleotide sequence or a variant thereof; and a nucleotide sequence encoding a target protein gene on the 3 side of the 5UTR regulation structure, into a cell in the presence of a protein specifically binding to the RNA motifs, wherein a translational level is decreased as the number of bases of the spacer decreases, and the translational level is decreased as the number of the RNA motifs increases.


Patent
Toyota Jidosha Kabushiki Kaisha and Kyoto University | Date: 2016-08-08

An object of the present invention is to provide a fluoride ion battery in which excess voltage at the time of charging is decreased. The present invention achieves the object by providing a fluoride ion battery comprising a cathode active material layer containing a cathode active material, an anode active material layer containing an anode active material, and an electrolyte layer formed between the cathode active material layer and the anode active material layer; wherein the anode active material is an alloy containing at least a Ce element and a Pb element.


Patent
Toyota Jidosha Kabushiki Kaisha and Kyoto University | Date: 2016-08-31

A main object of the present invention is to provide an anode current collector that is capable of inhibiting the reaction with liquid electrolyte. The present invention achieves the object by providing an anode current collector to be used for a fluoride ion battery; and the anode current collector being a simple substance of Fe, Mg, or Ti, or an alloy containing one or more of these metal elements.


Patent
Denso Corporation and Kyoto University | Date: 2016-07-27

A proton conductor includes a coordination polymer having stoichiometrically metal ions, oxoanions, and proton coordinating molecules capable of undergoing protonation or deprotonation. The coordination polymer including coordination entities that are repeatedly coordinated to bond the coordination entities with one another. Each coordination entity is either a first coordination entity or a second coordination entity. The first coordination entity is one metal ion of the metal ions coordinated with either at least one oxoanion of the oxoanions or at least one proton coordinating molecule of the proton coordinating molecules. The second coordination entity is the metal ion coordinated with each of at least one oxoanion of the oxoanions and at least one proton coordinating molecule of the proton coordinating molecules. At least a part of the proton conductor is non-crystalline. The proton conductor has high ion conductivity at high temperature.


Patent
GS Yuasa International Ltd. and Kyoto University | Date: 2016-07-19

A storage battery includes a negative electrode including, as an active material, at least one of a metal capable of forming a dendrite and a metal compound thereof, a positive electrode, a separator, and an electrolyte containing an additive. In the storage battery, a concentration of the additive in the electrolyte in a region on a side of the negative electrode defined by the separator is higher than a concentration of the additive in a region on a side of the positive electrode.


Patent
GS Yuasa International Ltd. and Kyoto University | Date: 2016-07-19

An alkaline storage battery contains: a positive electrode; a negative electrode containing, as an active material, at least one of a metal capable of forming a dendrite and a metal compound thereof; and an alkaline electrolyte. The alkaline electrolyte contains a compound which is a chain saturated hydrocarbon at least partially having a hydrophilic functional group other than a hydroxyl group and having a molecular weight of 400 or more and less than 220000 in an amount of less than 15 g per 100 mL of the electrolyte.


A novel genetic factor for rheumatoid arthritis is searched for and used as a diagnostic marker. A method of testing for rheumatoid arthritis, comprising detecting an autoantibody to myelin basic protein in a biological sample from a subject. A test kit for rheumatoid arthritis, comprising myelin basic protein. A diagnostic marker for rheumatoid arthritis, comprising an antibody to myelin basic protein. A method of judging the risk to develop rheumatoid arthritis, comprising identifying the single nucleotide polymorphism of a nucleotide present in the myelin basic protein gene of a subject or identifying the single nucleotide polymorphism of a nucleotide that is in linkage disequilibrium with the first mentioned nucleotide. A kit for judging the risk to develop rheumatoid arthritis, comprising nucleic acid probes and/or nucleic acid primers capable of detecting the single nucleotide polymorphism of a nucleotide present in the myelin basic protein gene of a subject or the single nucleotide polymorphism of a nucleotide that is in linkage disequilibrium with the first mentioned nucleotide. A method of screening for a substance effective as a prophylactic and/or therapeutic for rheumatoid arthritis, comprising adding a test substance to a myelin basic protein gene-expressing cell and then determining the expression level of the myelin basic protein gene or the gene product thereof.


An object of the present invention is to provide a technology of dispersing cellulose readily in a hydrophobic substance such as a resin by treating cellulose being a hydrophilic substance in a system that contains water as a main medium with a polymer dispersant, which has been developed for dispersing a fine and hydrophobic substance such as a pigment, in a simple and efficient manner without conducting surface modification of nanocellulose or other treatments. The object is solved by a process for producing a readily dispersible cellulose composition, the process including dissolving a polymer dispersant having a block copolymer structure having a resin-affinitive segment A and a cellulose-adsorptive segment B in a hydrophilic organic solvent solution, adding a surface active agent to the resultant solution, thereafter adding water to the resultant mixture to prepare an aqueous dispersion treatment agent containing the polymer dispersant, and adding the obtained aqueous dispersion treatment agent to cellulose in a water-containing state or in a dry state, thereby obtaining a readily dispersible cellulose composition. The object is also solved by a process for producing an aqueous dispersion treatment agent for use in the process for producing a readily dispersible cellulose composition, the readily dispersible cellulose composition, and a cellulose-dispersed resin composition using the readily dispersible cellulose composition.


Patent
Kyoto University and ARKRAY Inc. | Date: 2017-01-04

Provided is a radioactive labeled compound that can detect a secondary mutation of an epidermal growth factor receptor and which is a compound represented by Formula (1) described below or a pharmaceutically acceptable salt thereof. In Formula (1), L_(1) is an alkanediyl group having 1 to 5 carbon atoms or an alkenediyl carbonyl group having 3 to 8 carbon atoms, R_(1) is a radioactive halogen atom, or 5- to 7-membered monocyclic nitrogen-containing heterocycloalkyl that may have one substituent, R_(2) is a 6- to 8-membered aryl group or nitrogen-containing heteroaryl group with one substituent, R_(1) or R_(2) contains a radioactive halogen atom or a radioactive carbon atom (^(11)C), and Y is -NH- or -O-.

Loading Kyoto University collaborators
Loading Kyoto University collaborators